Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06638021 · ClinicalTrials.gov registry record · NA
Targeted EHR-based Communication of Diagnostic Uncertainty in the ED
A NA study of Diagnostic Uncertainty, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06638021 is a NA study of Diagnostic Uncertainty that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06638021, a NA study of Diagnostic Uncertainty, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the clinical trial is to evaluate the preliminary effectiveness and the implementation feasibility of the Targeted EHR-based Communication about Uncertainty (TECU) strategy in improving the quality of care transitions from the emergency department (ED) to home. The overall specific aims related to the trial are to test the preliminary effectiveness of TECU compared to standard of care in reducing patient uncertainty and return ED visits and evaluate the adoption of TECU, exploring patient and clinician barriers and facilitators to TECU implementation.
Conditions Studied
Interventions
- BEHAVIORAL Targeted EHR-based Communication of Diagnostic Uncertainty (TECU)
Study Locations (1)
Pennsylvania
- Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-11-05 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06638021
The ClinicalTrials.gov registry entry for NCT06638021 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diagnostic Uncertainty appearing as the primary indexed condition, and to 1 intervention - of which Targeted EHR-based Communication of Diagnostic Uncertainty (TECU) is the first listed.
NCT06638021 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06638021 about?
NCT06638021 is a clinical study titled "Targeted EHR-based Communication of Diagnostic Uncertainty in the ED". The goal of the clinical trial is to evaluate the preliminary effectiveness and the implementation feasibility of the Targeted EHR-based Communication about Uncertainty (TECU) strategy in improving the quality of care transitions from the emergency department (ED) to home. The overall specific aims ...
What is the current status of trial NCT06638021?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-11-05. Estimated completion is 2027-07-01.
What conditions does trial NCT06638021 study?
This clinical trial studies the following conditions: Diagnostic Uncertainty.
What interventions are being tested in trial NCT06638021?
The interventions under investigation include: Targeted EHR-based Communication of Diagnostic Uncertainty (TECU) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06638021?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06638021 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.